Shanghai Xuerong Bio-Technology Co Ltd Strategic Asset Allocation Index

Latest as of June 2023: 156.5%

Shanghai Xuerong Bio-Technology Co Ltd strategic asset allocation index. Shanghai Xuerong Bio-Technology Co Ltd (300511) has a Strategic Asset Allocation Index of 156.5% as of June 2023. Strategic assets (PP&E of CN¥2.68 Billion plus long-term investments of CN¥-) total CN¥2.68 Billion, measured against net assets of CN¥1.71 Billion. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base. See Shanghai Xuerong Bio-Technology Co Ltd (300511) balance sheet quality index to measure how much of total assets are equity-financed.

SAAI

156.5%
Strategic Assets / Net Assets

Strategic Assets

CN¥2.68 Billion
PP&E + LT Investments

PP&E

CN¥2.68 Billion
CNY

Net Assets

CN¥1.71 Billion
CNY

Strategic Asset Allocation Index of Shanghai Xuerong Bio-Technology Co Ltd (2012–2021)

Strategic asset allocation index of Shanghai Xuerong Bio-Technology Co Ltd from 2012 to 2021. This chart shows how Shanghai Xuerong Bio-Technology Co Ltd's Strategic Asset Allocation Index has evolved across 10 annual periods from 2012 to 2021. As of June 2023, the index stands at 156.5%, representing strategic assets of CN¥2.68 Billion against net assets of CN¥1.71 Billion CNY. Check Shanghai Xuerong Bio-Technology Co Ltd tangible equity quality to evaluate the tangible quality of the company's equity base.

Shanghai Xuerong Bio-Technology Co Ltd Strategic Asset Allocation Index by Year (2012–2021)

Shanghai Xuerong Bio-Technology Co Ltd strategic asset allocation index by year from 2012 to 2021. The table below presents the year-by-year Strategic Asset Allocation Index for Shanghai Xuerong Bio-Technology Co Ltd from 2012 to 2021, covering 10 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. For live market cap and overall valuation, see Shanghai Xuerong Bio-Technology Co Ltd (300511) total market value.

Year SAAI Strategic Assets (CNY) PP&E LT Investments Net Assets Change (pp)
2021 178.2% CN¥2.95 Billion CN¥2.95 Billion CN¥- CN¥1.65 Billion ▲ +39.7 pp
2020 138.4% CN¥2.80 Billion CN¥2.80 Billion CN¥- CN¥2.02 Billion ▼ -16.3 pp
2019 154.7% CN¥2.69 Billion CN¥2.69 Billion CN¥- CN¥1.74 Billion ▼ -11.1 pp
2018 165.8% CN¥2.60 Billion CN¥2.60 Billion CN¥- CN¥1.57 Billion ▼ -26.3 pp
2017 192.1% CN¥2.72 Billion CN¥2.72 Billion CN¥- CN¥1.42 Billion ▲ +60.4 pp
2016 131.6% CN¥1.70 Billion CN¥1.70 Billion CN¥- CN¥1.29 Billion ▼ -57.9 pp
2015 189.5% CN¥1.22 Billion CN¥1.22 Billion CN¥- CN¥642.99 Million ▼ -14.3 pp
2014 203.8% CN¥1.08 Billion CN¥1.08 Billion CN¥- CN¥529.00 Million ▼ -31.9 pp
2013 235.7% CN¥1.02 Billion CN¥1.02 Billion CN¥- CN¥433.49 Million ▼ -26.3 pp
2012 261.9% CN¥998.31 Million CN¥998.31 Million CN¥- CN¥381.15 Million —
pp = percentage points